arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

MANNATECH INC

MTEX
$4.87 0.00 (0.00%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
72 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
59
Health
Fair
Moderately Bullish
auto_awesome

Analytical Summary

MANNATECH INC demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $9.4M
Dividend Yield
Revenue Growth -6.2%
Op. Margin -0.7%
ROIC 5.5%
FCF / Share $0.52
Trailing P/E 9.9x
Price / Book
FCF Yield 10.6%
Debt / Equity -0.50
info Valuation on last close. End-of-day price, Aug 3, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$24.92M
↓ -6.2%
Net Income Profit after all expenses
$950.00K
↑ +108.4%
Operating Margin Operating profit as % of sales
-0.7%
↓ -22.6% 27th
FCF / Share Free cash flow per share
$0.52
↑ +152.9%
Long-Term Debt Long-term obligations
$2.75M
— 0.0%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
19
Returns
100
Financial Health
73
Cash Quality
32

Dividend History

Dividend / share · sourced from SEC filings
$0.20 Latest / share
+0.0% YoY
+8.1% 7-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 72 quarters